Not Valid for Submission
B55 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of leishmaniasis. The code is NOT valid for the year 2020 for the submission of HIPAA-covered transactions.
Consider the following ICD-10 codes with a higher level of specificity:
- B55.0 - Visceral leishmaniasis
- B55.1 - Cutaneous leishmaniasis
- B55.2 - Mucocutaneous leishmaniasis
- B55.9 - ... unspecified
- LEISHMANIASIS-. a disease caused by any of a number of species of protozoa in the genus leishmania. there are four major clinical types of this infection: cutaneous old and new world leishmaniasis cutaneous diffuse cutaneous leishmaniasis diffuse cutaneous mucocutaneous leishmaniasis mucocutaneous and visceral leishmaniasis visceral.
- LEISHMANIASIS MUCOCUTANEOUS-. a disease characterized by the chronic progressive spread of lesions from new world cutaneous leishmaniasis caused by species of the l. braziliensis complex to the nasal pharyngeal and buccal mucosa some time after the appearance of the initial cutaneous lesion. nasal obstruction and epistaxis are frequent presenting symptoms.
- LEISHMANIASIS VISCERAL-. a chronic disease caused by leishmania donovani and transmitted by the bite of several sandflies of the genera phlebotomus and lutzomyia. it is commonly characterized by fever chills vomiting anemia hepatosplenomegaly leukopenia hypergammaglobulinemia emaciation and an earth gray color of the skin. the disease is classified into three main types according to geographic distribution: indian mediterranean or infantile and african.
- LEISHMANIASIS CUTANEOUS-. an endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. the disease has been divided into old and new world forms. old world leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the l. tropica and l. aethiopica complexes as well as by species of the l. major genus. new world leishmaniasis also called american leishmaniasis occurs in south and central america and is caused by species of the l. mexicana or l. braziliensis complexes.
- LEISHMANIASIS DIFFUSE CUTANEOUS-. a form of leishmaniasis cutaneous caused by leishmania aethiopica in ethiopia and kenya l. pifanoi in venezuela l. braziliensis in south america and l. mexicana in central america. this disease is characterized by massive dissemination of skin lesions without visceral involvement.
- LEISHMANIASIS VACCINES-. vaccines or candidate vaccines used to prevent infection with leishmania.
Certain infectious and parasitic diseases (A00–B99)
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set)
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020